Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

How do you tailor seizure medications in patients who become pregnant or are family planning?

1 Answers

Mednet Member
Mednet Member
Neurology · USF Health

There are basic guidelines for planning pregnancy: folate 4 mg QD, good prenatal care. All seizure medications are basically comparable except valproate as far as birth malformation. Monotherapy if possible, and low dose if possible. Modern medications are generally preferred over old ones. For the ...

For patients with post-stroke headaches, what treatment do you typically recommend?

1 Answers

Mednet Member
Mednet Member
Neurology · Barrow Neurological Institute

First off, I usually recommend treating the headache based on phenotype. So if the headache meets ICHD-3 criteria for migraine, then treat as migraine.Great resource for current treatment recommendation in general for migraine: Ailani et al., PMID 34160823.In terms of considerations specific for str...

In which patients with autoimmune or inflammatory conditions are you recommending a 3rd dose of the mRNA COVID vaccine?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Beth Israel Deaconess Medical Center

We found that many of the patients on immune suppressive medications do not have an appropriate response to the initial 2 doses of mRNA COVID19 vaccines. At this point, I recommend a 3rd dose to all the patients on immune suppressive medications, prioritizing the ones with known low titers of SARS-C...

In the rare setting of enoxaparin injection-induced abdominal wall hematoma in patients requiring long-term anticoagulation, what is your timeline for restarting anticoagulation?

1 Answers

Mednet Member
Mednet Member
Hematology · Mayo Clinic

Abdominal wall hematomas typically occur when a vessel has inadvertently been injured during injection. Timing of resumption of anticoagulant will vary with the underlying indication for anticoagulants. For a high-risk indication, eg multiple cardiac valves in patients with history of stroke, I woul...

What is your approach to the management of hot flashes in a patient who wants to use herbal medicine?

3
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Duke University

Hot flashes are so bothersome to some postmenopausal women, especially those with breast cancer in whom we discourage the use of estrogen or potentially estrogenic, that we now have evidence from randomized trials to help guide treatment. With regard to nonprescription therapies, data thus far suppo...

What is your approach to a patient with rheumatoid arthritis and moderate disease activity on 25 mg of PO methotrexate?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Audie L. Murphy Memorial Veterans' Hospital

Switching to sub cu may work for low disease activity, but not moderate.

How do you approach treatment of osteoporosis in patients with CKD who develop a fragility fracture while on denosumab?

7
1 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

The only option left at this point is a PTH compound. Please it or not, it still works every time in subjects with a secondary elevation of PTH. I would try either Forteo or Tymlos for a few months and see if the patient can tolerate it and if the calcium numbers remain stable. I am not sure about r...

How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Beth Israel Deaconess Medical Center

At this point, I am advising the patients to do the 3rd vaccine at least 5 months after the previous Rituximab dose. Whenever feasible, I test them for B cell reconstitution prior to vaccination, and may delay the vaccination if B cells are undetectable.

How do you approach prophylaxis against glucocorticoid-induced osteoporosis in patients with end-stage renal disease on dialysis?

4
1 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

Treating patients with end-stage renal disease on glucocorticoids to prevent bone loss is a challenge. A patient with end-stage renal disease cannot be treated with bisphosphonates. However, denosumab the RANKL antibody has no restrictions regarding renal disease. So my suggestion is to treat a pati...

How do you manage ADHD in patients with Tourette syndrome?

1 Answers

Mednet Member
Mednet Member
Neurology · SUNY Downstate Medical Center

Most people start with guanfacine, clonidine, or atomoxetine but you can still try stimulants first.